Inhibition of miR‐34b and miR‐34c enhances α‐synuclein expression in Parkinson's disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Mounting evidence suggests that microRNA (miR) dysregulation contributes to neurodegenerative disorders including Parkinson's disease (PD). MiR‐34b and miR‐34c have been previously shown to be down‐regulated in the brains of patients with PD. Here, we demonstrate that miR‐34b and miR‐34c repress the expression of α‐synuclein (α‐syn), a key protein in PD pathogenesis. Inhibition of miR‐34b and miR‐34c expression in human dopaminergic SH‐SY5Y cells increased α‐syn levels and stimulated aggregate formation. Additionally, a single nucleotide polymorphism (SNP) in the 3′‐UTR of α‐syn was found to lower the miR‐34b‐mediated repression of the protein. Our results suggest that down‐regulation of miR‐34b and miR‐34c in the brain, as well as an SNP in the 3′‐UTR of α‐syn can increase α‐syn expression, possibly contributing to PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Fast and effective prediction of microRNA/target duplexes
REHMSMEIER, M., STEFFEN, P., HÖCHSMANN, M., & GIEGERICH, R. (2004) · RNA · doi:10.1261/rna.5248604 · Cited by 2,560 · cited 1×
“Computational analysis using RNAhybrid algorithm [16] predicted base pairing with two target sites for miR-34b and one target site for miR-34c within the a-syn mRNA.”
A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons
Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187
Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation
Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · cited 2×
“Point mutations in the a-syn gene are linked to dominantly inherited PD [2], and individuals with multiplication of this gene locus develop PD with an early-onset age and phenotypic severity that are consistent with a gene dosage effect [3,4].”
Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 655
Self-citation(2004) · doi:10.1002/ana.10846 · Cited by 614
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 482 · cited 3×
“expression of miR-34b and miR-34c in the substantia nigra [14], which was confirmed by a recent report [15].”
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 454
Wang, G., van der Walt, J. M., Mayhew, G., Li, Y.-J., Züchner, S., Scott, W. K., Martin, E. R., & Vance, J. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.021 · Cited by 440 · cited 1×
“This genetic variation lies within a predicted binding region for miR-433 [24].”
Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
Martins, M., Rosa, A., Guedes, L. C., Fonseca, B. V., Gotovac, K., Violante, S., Mestre, T., Coelho, M., Rosa, M. M., Martin, E. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025443 · Cited by 245
MicroRNAs in neurodegenerative diseases and their therapeutic potential
Junn, E., & Mouradian, M. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.002 · Cited by 186
Self-citationSNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
Mata, I. F., Shi, M., Agarwal, P., Chung, K. A., Edwards, K. L., Factor, S. A., Galasko, D. R., Ginghina, C., Griffith, A., Higgins, D. S., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.279 · Cited by 177
Gründemann, J., Schlaudraff, F., Haeckel, O., & Liss, B. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn084 · Cited by 174
MicroRNAs in Parkinson's disease
Harraz, M. M., Dawson, T. M., & Dawson, V. L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.01.005 · Cited by 160
Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls
Cardo, L. F., Coto, E., Mena, L., Ribacoba, R., Moris, G., Menéndez, M., & Alvarez, V. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6900-8 · Cited by 153
Villar-Menéndez, I., Porta, S., Buira, S. P., Pereira‐Veiga, T., Díaz-Sánchez, S., Albasanz, J. L., Ferrer, I., Martín, M., & Barrachina, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.030 · Cited by 112 · cited 2×
“expression of miR-34b and miR-34c in the substantia nigra [14], which was confirmed by a recent report [15].”
Global microRNA Expression Profiling of Caenorhabditis elegans Parkinson's Disease Models
Asikainen, S., Rudgalvyte, M., Heikkinen, L., Louhiranta, K., Lakso, M., Wong, G., & Nass, R. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9325-1 · Cited by 93
de Mena, L., Cardo, L. F., Coto, E., Miar, A., Díaz, M., Corao, A. I., Alonso, B., Ribacoba, R., Salvador, C., Menéndez‐González, M., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.019 · Cited by 51 · cited 1×
“However, other reports have failed to replicate an association between SNPs of FGF20 and PD risk, or the connection between the variation rs12720208 and a-syn protein levels [25,26].”
Schlaudraff, F., Gründemann, J., Fauler, M., Dragicevic, E., Hardy, J., & Liss, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.016 · Cited by 47 · cited 1×
“Even in sporadic PD patients, a-syn mRNA has been found to be significantly upregulated as assessed by quantitative RT-PCR using a pool of individual dopaminergic neurons isolated by UV-laser microdissection microscopy from postmortem brains [6,7].”
Deciphering the Function and Regulation of microRNAs in Alzheimer’s Disease and Parkinson’s Disease
Qiu, L., Zhang, W., Tan, E. K., & Zeng, L. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500149w · Cited by 44
Wider, C. W., Dächsel, J. C., Soto, A. I., Heckman, M. G., Diehl, N. N., Yue, M., Lincoln, S., Aasly, J. O., Haugarvoll, K., Trojanowski, J. Q., et al. (2009) · Movement Disorders · doi:10.1002/mds.22442 · Cited by 41 · cited 1×
“However, other reports have failed to replicate an association between SNPs of FGF20 and PD risk, or the connection between the variation rs12720208 and a-syn protein levels [25,26].”
Pan, F.-H., Dong, H., Ding, H., Ye, M., Liu, W., Wu, Y., Zhang, X., Chen, Z.-Y., Luo, Y., & Ding, X. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.01.025 · Cited by 27
Defining Larger Roles for “Tiny” RNA Molecules: Role of miRNAs in Neurodegeneration Research
Yelamanchili, S. V., & Fox, H. S. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9172-4 · Cited by 23
Cited by
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 291
MicroRNAs: Roles in Regulating Neuroinflammation
Gaudet, A. D., Fonken, L. K., Watkins, L. R., Nelson, R. J., & Popovich, P. G. (2018) · The Neuroscientist · doi:10.1177/1073858417721150 · Cited by 236
Slota, J. A., & Booth, S. A. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020035 · Cited by 229
“Multiple miRNAs, including miR-7, miR-153, miR-34b and miR-34c are known to repress the expression of α-synuclein, and are therefore protective by limiting its associated neurotoxicity and neuroinflammation [109,110].”
BackgroundFunctional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases
Wu, Y.-Y., & Kuo, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00636-z · Cited by 213
Stress-induced changes in miRNA biogenesis and functioning
Olejniczak, M., Kotowska-Zimmer, A., & Krzyzosiak, W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2591-0 · Cited by 172
“Further inhibition of miR-34b/c in SH-SY5Y cells increased α-syn levels and stimulated aggregate formation, thus confirming the role of the miR-34 family in neurodegeneration [163].”
Background
Metadata
- Authors
- Kabaria, S., Choi, D. C., Chaudhuri, A. D., Mouradian, M. M., & Junn, E.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2014-12-23
- Volume
- 589
- Issue
- 3
- Pages
- 319-325
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1982813561
- Cited by
- 172
- References
- 25
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.